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Localization, differentiation, and quantitative assessment of fat tissues have always
collected the interest of researchers. Nowadays, these topics are even more relevant
as obesity (the excess of fat tissue) is considered a real pathology requiring in some
cases pharmacological and surgical approaches. Several weight loss medications,
acting either on the metabolism or on the central nervous system, are currently under
preclinical or clinical investigation. Animal models of obesity have been developed and
are widely used in pharmaceutical research. The assessment of candidate drugs in
animal models requires non-invasive methods for longitudinal assessment of efficacy,
the main outcome being the amount of body fat. Fat tissues can be either quantified
in the entire animal or localized and measured in selected organs/regions of the body.
Fat tissues are characterized by peculiar contrast in several imaging modalities as for
example Magnetic Resonance Imaging (MRI) that can distinguish between fat and water
protons thank to their different magnetic resonance properties. Since fat tissues have
higher carbon/hydrogen content than other soft tissues and bones, they can be easily
assessed by Computed Tomography (CT) as well. Interestingly, MRI also discriminates
between white and brown adipose tissue (BAT); the latter has long been regarded
as a potential target for anti-obesity drugs because of its ability to enhance energy
consumption through increased thermogenesis. Positron Emission Tomography (PET)
performed with 18F-FDG as glucose analog radiotracer reflects well the metabolic rate in
body tissues and consequently is the technique of choice for studies of BAT metabolism.
This review will focus on the main, non-invasive imaging techniques (MRI, CT, and PET)
that are fundamental for the assessment, quantification and functional characterization
of fat deposits in small laboratory animals. The contribution of optical techniques, which
are currently regarded with increasing interest, will be also briefly described. For each
technique the physical principles of signal detection will be overviewed and some
relevant studies will be summarized. Far from being exhaustive, this review has the
purpose to highlight some strategies that can be adopted for the in vivo identification,
quantification, and functional characterization of adipose tissues mainly from the point
of view of biophysics and physiology.
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INTRODUCTION
Fat Tissue: General Characteristics
Fat tissue, or adipose tissue, is a type of connective tissue
whose predominant cell type is the fat cell, or the adipocyte.
In mammals there are two types of fat tissues: the white
adipose tissue (WAT) and the brown adipose tissue (BAT)
(Cinti, 2000). BAT is characterized by special fat cells showing
a multilocular lipid deposit, wherein thermogenesis takes place
by “burning” fatty acids in uncoupled mitochondria (Cannon
and Nedergaard, 2004). Instead, WAT cells typically present
one lipid vacuole and are the major site for body lipids
storage, especially triglycerides, serving as an energy deposit from
which fatty acids may be delivered through the bloodstream
to meet the body’s energy requirements during fast or intense,
enduring physical activity. Moreover, fat cells are plastic enough
so that fat tissue may serve as an aid to prevent trauma
injuries; fat cells may act as a heat insulator layer as well.
Other cell types are found in fat tissue, e.g., preadipocytes,
endothelial cells, pericytes (Rosen and Spiegelman, 2000),
immune cells (lymphocytes, T-cells, macrophages, neutrophils),
and multipotent stem cells (Tchoukalova et al., 2004; Carmon
et al., 2008; Kintscher et al., 2008; Cawthorn et al., 2012).
Overall, these cell types over number fat cells in adipose tissue;
nevertheless, fat cells represent about 90% of tissue volume
due to their large size ranging 20–200 microns. Fat tissue
also represents an endocrine tissue by producing a variety of
adipokines (e.g., leptin, visfatin, adipolin, and many others).
Adipokines act at the autocrine/paracrine and endocrine level
(Ronti et al., 2006). Adipokines participate in the regulation
of glucose and lipid metabolism, energy homeostasis, feeding
behavior, insulin sensitivity, and adipogenesis; they are also
involved in the regulation of vascular function and coagulation
(Romacho et al., 2014). Fat tissue also has a role in the
immune function. In non-obese subjects, immune cells resident
in fat tissue have housekeeping functions such as apoptotic
cell clearance, extracellular matrix remodeling, and angiogenesis
(Mathis, 2013). In obese subjects, excess of adipocytes produces
danger signals mimicking bacterial infection, and drives a
prototypic T helper 1 inflammatory response (Grant and Dixit,
2015).
Fat Tissue: Body Distribution
Fat tissue is distributed in several discrete anatomical deposits
in the body (Shen et al., 2003). It is well known that
women generally show higher adiposity than men. Moreover,
there is a sexual dimorphism in fat tissue distribution,
men accumulate more fat in the trunk region and women
accumulate more in the gluteofemoral region (Geer and Shen,
2009). Ethnicity is also a factor that influences body fat
distribution (Carroll et al., 2008). Over the last decades it
became clear that adipose tissue is not a single homogeneous
compartment; instead, it is a tissue with specific regional
depots whose biological functions may vary (Vanderburgh,
1992; Schoen et al., 1996) and individual adipose tissue
deposits are more closely correlated with physiological and
pathological processes than total adipose tissue mass (Kelley
et al., 2000). In humans, the largest fat tissue deposit is the
subcutaneous adipose tissue, representing about 80% of body
fat (Frayn and Karpe, 2014). Within subcutaneous adipose
tissue different sub-deposits have been identified: the abdominal,
gluteal, and femoral sub-deposits. The subcutaneous adipose
tissue is divided into superficial and deep layers by the fascia
superficialis. These layers have different functions and different
correlations with metabolic complications of obesity (Smith
et al., 2001). Visceral adipose tissue is found around organs
in the thoracic and, to a greater extent, in the abdominal
cavity. It has morphological and functional differences from
subcutaneous adipose tissue. For example, visceral adipose tissue
contains larger, insulin-resistant adipocytes, presents a well-
developed vasculature and abundant innervation, and it is more
sensitive to lipolysis. On the other hand, subcutaneous fat
shows smaller, insulin-sensitive fat cells with less developed
vasculature and nerve supply (Mårin et al., 1992; Bjorntorp,
2000). Subcutaneous and visceral adipose tissues have peculiar
adipokine expression and secretion profiles (Kershaw and Flier,
2004). Visceral adipose tissue releases larger amounts of pro-
inflammatory cytokines in the vena porta, which directly impacts
liver metabolism; in its turn, subcutaneous adipose tissue
releases more leptin and larger amounts of adiponectin, an
anti-inflammatory and insulin-sensitizing adipokine (Ibrahim,
2010). Therefore, the ability to identify and quantify different
adipose deposits non-invasively, which is a peculiar feature
of in vivo imaging techniques, appears relevant to obesity
research.
Triglycerides may also be deposited within cells of non-
adipose tissue that normally contain only small amounts of
fat; this is called ectopic fat deposition (Shulman, 2014) and it
is usually associated with obesity and positive energy balance.
Excess lipids can accumulate in the heart, liver, skeletal muscle,
and pancreas probably because the adipose tissue is no longer
capable of sequestering nutritional lipids. Ectopic fat deposits
have been claimed as risk factors for disease development
(Mathieu et al., 2014).
Fat Tissue: Body Composition Analysis
In the context of body composition analysis, fat (adipose) tissue
and body fat are not synonymous. When the five levels (I,
atomic; II, molecular, III, cellular; IV, tissue/system; V, whole
body) approach to body composition is adopted (Wang et al.,
1992), fat tissue is considered at level IV as a specialized
loose connective tissue containing lipid-laden adipocytes as
well as intra- and extracellular water, interstitial cells, blood
vessels, etc. Instead, body fat at level II is considered as
the total mass of body lipids (especially triglycerides). These
lipids are mainly contained in the lipidic droplets of fat
tissue adipocytes, but also in intermuscular adipocytes, in
sparse adipocytes of interstitial tissue as well as in muscle
cells, hepatocytes, cell membranes, etc. As a result, the total
amount of fat tissue and body lipids may be similar, but
not identical (Tothill et al., 1996). Traditionally, body fat has
been evaluated with a two-compartment model, i.e., subdividing
body mass in fat mass and fat-free mass (lean mass). For
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decades, the standard method for determining fat mass has
been underwater weighing; later on, body water dilution,
bioelectrical impedance, and air-displacement plethysmography
have been used (Pietrobelli et al., 1998) until three-dimensional
anthropometry (Wells et al., 2008; Giachetti et al., 2015). In
parallel, several imaging techniques emerged as useful tools
for body composition analysis on a multi-compartmental basis,
e.g., magnetic resonance imaging (MRI), computed tomography
(CT), ultrasounds (US), and positron emission tomography
(PET).
Adipose Tissue as a Target for
Anti-obesity Drugs
Obesity is nowadays recognized as a real pathological state
requiring pharmacological and in some cases even surgical
treatment. Several drugs for obesity treatment have been
marketed over the past few years, but their efficacy was limited
and severe adverse effects have often been reported. Anti-
obesity drugs on the market or in clinical trials have been
recently reviewed (Giordano et al., 2016). Their mechanism
of action broadly falls in two categories: drugs that reduce
nutrients absorption and anorexic drugs that act on the central
nervous system to induce sense of satiety. An innovative
mechanism of action for anti-obesity drugs has been more
recently proposed and it consists in promoting conversion
of WAT into BAT (Giordano et al., 2016). Indeed, it
is well known that adult WAT can convert into BAT
(browning), this conversion being triggered by several conditions
including low ambient temperature, physical exercise or
β3-adrenoceptor stimulation. White adipocytes converted to
brown adipocytes are considered a new type of brown fat
cells named beige adipocytes. A number of molecular targets
that can potentially promote conversion of WAT into BAT
have been identified recently and reviewed (Giordano et al.,
2016). Interestingly, the target of such adipose conversion is
the visceral WAT, which is inflamed in obese subjects and
possibly involved in most of the adverse clinical correlates
of obesity, e.g., metabolic syndrome. In the context of
pharmacological research in anti-obesity drugs, suitable animal
models and related imaging techniques are needed. In this
review, we will examine the contribution of different imaging
techniques to the issue of in vivo fat tissue identification,
quantification, and functional characterization. While most
of such imaging studies have been carried out in humans,
longitudinal, mechanistic investigations of the metabolic and
health correlates of excess/paucity of body fat are better
performed in experimental animals. Small rodents, especially
mice and rats, are extensively used in preclinical studies aimed
at clarifying the causes and mechanisms of metabolic syndrome,
diabetes, and obesity (Rees and Alcolado, 2005; Varga et al.,
2010; Kanasaki and Koya, 2011) as well as in studies aimed
at defining the effect of candidate drugs. Since BAT appears
a potential new target tissue for anti-obesity drugs, special
attention will be devoted to imaging techniques allowing for
identification, quantification, and functional state assessment
of BAT.
IMAGING TECHNIQUES FOR
DETECTION OF FAT TISSUES IN
PRECLINICAL STUDIES
Preclinical imaging has been widely employed in the study of
obesity and metabolism. Preclinical protocols for assessing whole
body and regional adipose tissue content have been reported
using MRI, CT, and Dual-energy X-ray Absorptiometry (DXA)
(Sjögren et al., 2001; Sasser et al., 2012; Metzinger et al., 2014).
While DXA has been used to accurately estimate lean and fat
mass in rodents, as a bi-dimensional radiological technique, it
does not provide tridimensional information on fat volume and
distribution (Luu et al., 2009); accordingly results obtained with
DXA are not reported in this review. The interested reader is
referred to the excellent reviews from Albanese et al. (2003)
and Toombs et al. (2012). US has been used as an effective
and economic technique to assess body composition in humans
although its accuracy is strongly dependent on the operator
proficiency (Wang et al., 2014). Moreover, applications of US to
animal models of obesity and metabolic disorders are still limited;
consequently US will not be discussed in this review. 18FDG-PET
has been employed in studies of BAT and metabolic disease (van
der Veen et al., 2012). Preclinical imaging provides longitudinal
imaging of obesity models, studies of molecular mechanisms
of obesity and evaluation of candidate obesity therapeutics. Far
from being exhaustive, this review has the purpose to highlight
some strategies that can be adopted for the in vivo identification,
quantification, and functional characterization of adipose tissues
mainly from the point of view of biophysics and physiology.
MR-Techniques
Magnetic Resonance Imaging and Magnetic Resonance
Spectroscopy (MRS) are currently considered to be the most
comprehensive tools for quantification of fat in living organisms
(Hu and Kan, 2013). Of note, MRI and MRS can be performed
by a single instrument and within the same experimental
setup. MRI and MRS have the same underlying concepts and
exploit the difference in the resonance frequency between
water and fat protons, a phenomenon known as chemical shift.
Representative ex vivo and in vivo spectra obtained from WAT
in mice are reported in Figures 1A,B where several proton
resonances attributable to different chemical environments
can be distinguished. The water proton resonance occurring at
4.7 ppm is barely visible in the WAT tissue. The signal at 1.3 ppm
corresponds to the CH2 methylene protons of the lipid chain,
shown in Figure 1C, and represents the bigger component in the
triglyceride spectrum (Bley et al., 2010). The spectrum reported
in Figure 1B has been obtained after carefully shimming over
a small Volume-of-Interest (VOI) and its spectral resolution is
comparable to the resolution of the ex vivo spectrum reported in
Figure 1A. However in most experimental setups only a few of
the triglyceride spectral lines can be detected (see e.g., the typical
liver spectrum in Figure 1 of Reeder et al., 2011). Consequently,
in most of applications of MRS for determination of water/fat
content, two peaks are considered: the water peak (4.7 ppm) and
the CH2 protons of the lipid chain peak (1.3 ppm), the latter
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FIGURE 1 | Magnetic Resonance Spectroscopy and Imaging of fat tissues. Representative ex vivo (A) and in vivo (B) spectra of inguinal white adipose tissue.
The areas under each peak are proportional to the number of protons in a given chemical environment within a triglyceride molecule (C) (from Giarola et al., 2011
reprinted with permission). (D,E) 3D reconstruction of MR images of whole trunk and selected structures in an ob/ob mouse showing the space distribution of fat
deposits (from Calderan et al., 2006, reprinted with permission); (F) localization of the principal BAT depots and some WAT depots in the mouse (from Vosselman
et al., 2013, reprinted with permission). Chemical shift selective transversal MR images at the level of the interscapular BAT in a living rat: (G) fat image; (H) water
image. IBAT is marked by a triangle (from Lunati et al., 1999, reprinted with permission).
containing more than 10 times the signal of any other fat peak
(Bley et al., 2010). The fat and water content of a given tissue can
be estimated from proton spectra as the ratio between the area of
the water and CH2 protons peaks.
Proton spectra acquired with high spectral resolution are
used to chemically characterize lipid molecules in vivo (Giarola
et al., 2011; Mosconi et al., 2011; Ye et al., 2012) in terms of
unsaturation, poly-unsaturation index, and mean chain length.
Quantification of protons corresponding to a certain chemical
species requires suitable spectra analysis generally performed
using commercial software (Giarola et al., 2011; Mosconi et al.,
2011, 2014). To the best of our knowledge, ours was one
of the first groups to suggest that in vivo MRS can provide
information about fat composition in living animals (Lunati
et al., 2001). Afterward, Mosconi et al. (2011) demonstrated that
WAT in obese Zucker rats, a widely used experimental model
for diabetes and obesity, is characterized by lower unsaturation
and polyunsaturation index compared with controls (lean Zucker
rats) thereby confirming the hypothesis that obese and lean
Zucker rats have different adipose tissue composition. Ye et al.
(2012) applied MRS to study lipids in the liver of ob/ob mice at 9.4
T and demonstrated that the mean chain length was significantly
longer and the fraction of monounsaturated lipids higher in
ob/ob mice than in control.
The fact that water and methylene lipid spectral lines are
separated by about 3.5 ppm (corresponding to 420, 700, 1043 Hz
at 3, 4.7, and 7 T, respectively) is the base for fat/water selective
imaging. Several reviews have been recently published describing
details of MRI techniques used to obtain water and fat separation
(Bley et al., 2010; Reeder et al., 2011; Hu and Kan, 2013).
Briefly, these techniques can be divided into frequency-selective
or phase-selective. In frequency-selective imaging, the excitation
pulse is shaped to selectively excite water or fat proton signal
prior to acquisition. In this case the signal will be detected only
from water or fat. In a different approach, frequency-selective
pulses are first applied to suppress water or fat signal and then
the signal of the unsuppressed chemical species is acquired. Fat
selective excitation has been used to characterize the water/fat
content of interscapular BAT and visceral WAT in the laboratory
animal (Lunati et al., 1999) and it is routinely applied to suppress
fat signal in clinical examinations where the high intensity signal
coming from fat can mask the signal coming from other organs
or pathologies.
The same physical property, i.e., chemical shift of water and
methylene protons, is exploited in the phase-selective imaging
methods originally proposed by Dixon (1984). A review of
methods and applications of phase selective imaging has been
recently published (Hu and Kan, 2013).
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Compared to tissue water protons, fat protons are
characterized by short longitudinal relaxation time (T1) and long
transversal relaxation time (T2). Indeed, the T1 relaxation time of
fat tissues is one of the shortest measurable in vivo (Hu and Kan,
2013). Accordingly, fat tissue appears brightest in T1 weighed
images thereby allowing for easy quantification of fat volume
trough threshold-based segmentation of images (Hu and Kan,
2013). This is defined the relaxometry-based approach while the
above mentioned methods, based on the chemical shift difference
between water and fat proton, are defined chemical shift-based
approaches. Relaxometry-based approaches are widely applied in
small animal imaging. Calderan et al. (2006) used this approach
to study the fat distribution in ob/ob mice trough segmentation
of T1 weighted images and 3D reconstruction of fat depots and
internal organs (Figures 1D,E). The same approach was applied
in longitudinal studies of body fat accumulation in cathepsin
K null mice and its wild type during treatment with high fat
diet for 12 weeks (Funicello et al., 2007). The above mentioned
differences in T1 and T2 values between water and fat protons
permit analysis of body composition in awake small laboratory
animals with simple acquisitions of the nuclear magnetic
resonance (NMR) signal in the time domain from the whole
body. Small bench top NMR instruments are now available that
allow precise measurement of lean, fat, and free fluid content in
laboratory animals which are widely used in pharmaceutical as
well as in diabetes and obesity research. Such approach was used
to measure body mass composition (fat, lean, and free fluids)
in Ghrelin-receptor null transgenic mice in comparison to wild
type, in order to comprehend the action mechanism of a new
drug acting as a selective and potent antagonist of the Ghrelin
receptor (Costantini et al., 2011).
The anatomical localization of the principal BAT and some
WAT deposits are shown in Figure 1F. It is noteworthy that
MRI can distinguish between BAT and WAT. It has long
been known that MRI findings correlate with ultrastructural
patterns of BAT in laboratory animals (Osculati et al., 1991); this
study was performed at different ages indicating that MRI is a
reliable tool to investigate BAT tissue along its age-associated
changes. Moreover, MRI allows for accurate determination of
BAT deposits volume in living animals and reveals tissue changes
associated with temperature manipulation, findings confirmed by
histological and ultrastructural analysis (Sbarbati et al., 1991).
Modification induced in BAT by interferon were studied with
MRI and confirmed by histology and TEM. In particular, in
treated mice, the interscapular BAT (iBAT) was found to be
slightly enlarged and showed inhomogeneous areas of lipid
accumulation (Sbarbati et al., 1995). As shown in Figures 1G,H
unequivocal definition of BAT deposits can be obtained using
chemical shift selective imaging for fat and water protons; the
experimental paradigm was validated in rats at 4.7 T (Sbarbati
et al., 1997). MRI with fat selective excitation and correction
for the T2 relaxation time was applied to quantify fat and
water content in the iBAT of rats at 4.7 T in order to obtain
lipidic maps of this tissue (Lunati et al., 1999). Chen et al.
(2012) demonstrated the feasibility of estimating BAT volume
and metabolic function in vivo in rats at a 9.4 T using sequences
available from clinical MR scanners. Specifically, they measured
the volume distribution of BAT with MRI sequences showing
strong fat-water contrast, and investigated BAT volume by
utilizing spin-echo MRI sequences. MRI-estimated BAT volumes
were compared with the mass of the excised samples. Moreover
they were able to map the hemodynamic responses to changes
in BAT metabolism induced pharmacologically by the β3-
adrenergic receptor agonist, CL-316,243 in comparison with PET
18F-FDG imaging, demonstrating the feasibility of BAT volume
and functionality assessment with routinely used MRI sequences.
It should be mentioned that over the past several years, BAT
activity in vivo has been primarily assessed by PET (or PET-
CT) scan following 18F-FDG administration to measure glucose
metabolism (see “PET imaging”). Another approach, the two-
point magnitude MRI, based on a slightly modified standard
MRI protocol, has been proposed to visualize mouse BAT
differentiating it from surrounding WAT at 11.7 T (Lindenberg
et al., 2014).
In order to discriminate between BAT and WAT in lean
and ob/ob mice, T2∗ relaxation times and proton density fat-
fraction values were measured in the two tissues (Hu et al.,
2012). To determine differences in fat-signal fraction (FF) from
chemical-shift-encoded water-fat MRI of iBAT, Smith et al.
studied mice housed at different ambient temperatures. They
found that lowering temperature leads to a significantly reduction
in BAT-FF, in accordance with the expected BAT involvement
in thermogenesis (Smith et al., 2013). Comparison between
BAT and WAT fat fractions in ob, seipin, and Fsp27 gene
knockout mice by chemical shift-selective imaging and (1)H-MR
spectroscopy was reported by Peng et al. (2013). Finally, the effect
of different diets on composition of intra-hepatocellular lipids as
well intra-abdominal, subcutaneous and total adipose tissue, and
BAT was measured in vivo with whole body 3D imaging (Bidar
et al., 2012).
Several novel approaches have recently been explored to
validate the in vivo quantification of BAT with MRI. In
particular a dual-echo sequence, both with and without spectral
presaturation inversion recovery (SPIR) fat suppression, was used
at 1.5 T and validated through comparison with histology and
18FDG-PET (Holstila et al., 2013). A new MRI method combined
intermolecular double-quantum coherence and the chemical
shift-encoded Dixon method in order to enable detection of
BAT cells mixed to other cells. The contrast in this technique
depends on the water-to-fat ratio at the cellular size scale,
which is smaller than the imaging voxel size (Bao et al., 2013).
Another method, based on the normally invisible intermolecular
multiple-quantum coherence (1)H MR signal has been proposed
(Branca et al., 2013). This method does not require special
hardware modifications and can overcome the partial volume
effect. Moreover, it exploits the characteristic structure of BAT
adipocytes to selectively image them, even when they are
intimately mixed with other cell types. The method was validated
in mice using PET scans and histology. The patterns of oxygen
consumption/perfusion were imaged by using blood-oxygen-
level-dependent MRI upon BAT activation (Khanna and Branca,
2012) and a well-localized signal drop in BAT found, related to a
substantial increase in oxygen consumption and the consequent
increase in blood deoxyhemoglobin levels. Sbarbati et al. (2006)
Frontiers in Pharmacology | www.frontiersin.org 5 September 2016 | Volume 7 | Article 336
fphar-07-00336 September 22, 2016 Time: 14:46 # 6
Marzola et al. Preclinical In vivo Imaging of Fat Tissue
used contrast enhanced MRI to study the effect of adrenergic
stimulation on iBAT: adrenergic stimulation performed 40 s
before MRI lead to a significantly higher enhancement of
signal intensity in iBAT compared to unstimulated tissue,
indicating that BAT stimulation is accompanied by increased
blood flow.
The use of hyperpolarized nuclei for the identification and
assessment of BAT function was proposed by two different
groups. The first one (Lau et al., 2014) investigated the
feasibility of using hyperpolarized (13)C imaging to quickly
(<1 min) identify activated BAT in an in vivo rodent model
following an infusion of pre-polarized [1-(13)C] pyruvate. Using
hyperpolarized xenon gas, the second one (Branca et al., 2014)
demonstrated a greater than 15-fold increase in xenon uptake
by BAT during stimulation of thermogenesis, thereby, obtaining
background-free maps of the tissue in both lean and obese mouse
phenotypes.
Computed Tomography
X-ray computed tomography (also called X-ray CT or simply
CT) is based on the combination of many X-ray images
taken from different angles to produce tomographic images
of a scanned object. For in vivo acquisitions, the most used
construction principle involves scanners with X-ray detector and
the radiation source mounted on a gantry that is rotated around
the examined object. The majority of the marketed scanners
use nano-microfocus X-ray tubes in which an electron beam is
focused by several magnetic lenses onto a focal spot of 1–10 µm
which interacts with a transmission target to produce the X-ray
radiation. Passing through the samples, X-rays are differently
absorbed by different materials; the transmitted radiation reaches
scintillator crystals and is converted in light signals. The light
is then lead by tapered glass fibers (Schambach et al., 2010)
to a detector which is often a charge coupled device camera
(CCD) and transformed in a digital image. A large series
of two-dimensional radiographic images are taken around a
single axis of rotation and trough suitable algorithms a three-
dimensional image of the inside of the object can be generated.
MicroCT systems are capable of volumetric CT analysis with
isotropic voxels spacing 50–100 µm (Holdsworth and Thornton,
2002).
The different ability of the anatomical structures to attenuate
the X-ray beam is responsible of the contrast in CT images.
The adipose tissue has different X-ray attenuation compared
to other soft tissues, and thus it has a distinct density in
microCT images (Figure 2A). Using microCT scanners with
X-ray photon energies in the range 15–75 keV the principal
modes of X-ray attenuation are photoelectric absorption and
Compton scattering. Which mode predominates depends on the
photon energy and the atomic number (Z) of the absorbing
element (Evans, 1955, chapter 25, Figure 1.1). Photoelectric
absorption predominates at low photon energies and in heavier
elements, while higher photon energies and lower Z nuclei
favor Compton scattering. Photoelectric absorption in materials
is proportional to Z4, this means an acute sensitivity of
photoelectric absorption to elemental composition. Instead
Compton scattering has unitary proportionality to Z. This
difference is important: it implies that photoelectric absorption
gives much stronger absorption image contrast, based on material
element composition, than Compton scattering. The elemental
composition of soft tissue is predominantly hydrogen (H), carbon
(C), nitrogen (N), and oxygen (O).
Elemental ratios in some representative biological tissues are
shown in Table 1. The content of C and O in fat is 57 and 30%,
respectively, while in muscle (typical of soft tissues other than fat)
the content of C and O is 12 and 73%, respectively.
The large difference in the carbon to oxygen ratio between
fat and lean tissues accounts for the difference in X-ray
absorption at X-ray energies where photoelectric absorption
is the predominant interaction mechanism, i.e., at photon
energies less than about 30 keV. C, N, and O are close to the
boundary between predominance of photoelectric absorption
and Compton scattering, at photon energies less than 50 keV
so they can attenuate X-rays by both modalities. Decreasing
X-ray photon energy, photoelectric absorption is favored and
the Z-based contrast will increase. This means that fat can
be imaged by microCT by using an appropriate X-ray energy
without causing excessive radiation dose to the animal.
Computed tomography images can be treated with a set
of software procedures (thresholds detection, segmentation)
in order to enhance contrast, i.e., increase difference among
anatomical structures enabling subsequent computational
analysis. After segmentation of 2D images, volumetric
reconstructions of different organs, including fat, can be
obtained as reported in Figures 2B,C.
Computed tomography imaging has natural applications to
bone imaging, with a special focus on bone architectures, bone
density and vascular imaging, thanks to the implementation of
novel vascular contrast agents (Holdsworth and Thornton, 2002).
Moreover, it is also able to provide three-dimensional density
maps with sufficient contrast to distinguish adipose tissue from
other tissues, fluids and cavities without contrast agents (Luu
et al., 2009). Noteworthy, it can not only measure the total volume
of adipose tissue within an animal, but can also identify and
quantify very small volumes of fat residing in discrete deposits
(Luu et al., 2009). Indeed, acquiring high-resolution images based
on the physical densities of the object allows discrimination of
subcutaneous adipose tissue and visceral adipose tissue (Judex
et al., 2010). As a non-invasive, in vivo technique CT provides
measurement of the total, visceral, and subcutaneous adiposity
in longitudinal studies (Luu et al., 2009). Adipose volumes
determined by microCT and the weight of the explanted fat
pads are highly correlated, demonstrating that CT can accurately
monitor site-specific changes in adiposity (Judex et al., 2010).
From the experimenter’s point of view, it is important to note
that voxel densities of fat are relatively uniform throughout the
adipose tissue and partial volume effect in adipose tissue is less
important than in bony structures. Instead, a greater effort is
needed to set accurately voltage and current of the X-ray source
to optimize the contrast.
Although fat tissue is spanned over the entire body, it was
demonstrated that differences in total fat volume across various
animal species are congruent with differences in their abdominal
fat mass (Rubin et al., 2007). So scanning the entire mouse may
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FIGURE 2 | Computed Tomography of fat tissues. (A) In a reconstructed cross section of a microCT scan of a mouse thorax, the four tissues which are most
readily distinguished in microCT images on the basis of differing x-ray attenuation are bone, lung, fat and “lean” or non-fat soft tissue. All four tissues are clearly
visible in this image; the adipose tissue appears as the darker gray regions near the periphery of the thorax. Note that in this image lighter color means higher x-ray
attenuation and “density,” while darker color means low x-ray attenuation. Bone is saturated to white by narrowing of the reconstruction contrast limits to enhance
soft tissue visual contrast. (B) A segment VOI of the mouse thorax selected for fat analysis relative to a lung landmark (branching of trachea) shows adipose tissue in
green, lungs blue, bone gold. (C) Adipose tissue (green) in the lower surface rendered model image can be segmented and visualized on the basis of its lower X-ray
density vs. “lean” soft tissues. (Courtesy of Bruker microCT NV, Kontich Belgium).
TABLE 1 | Biological tissue elemental ratios by mass percentage (modified from Johns and Cunningham, 1983).
H C N O Na Mg P S K Ca
Atomic number Z 1 6 7 8 11 12 15 16 19 20
Fat 11.2 57.3 1.1 30.3 0.006
Water 11.2 88.8
Muscle 10.2 12.3 3.5 72.9 0.08 0.02 0.2 0.5 0.3 0.007
Bone 6.4 27.8 2.7 41.0 0.2 7.0 0.2 14.7
not be necessary and only the abdominal region can be acquired
saving acquisition time and dose administered to the patient
(Judex et al., 2010). For a quantitative analysis of discrete fat
deposits, manual drawing of contour lines is very time consuming
and does not yield adequate precision and accuracy; algorithms
have been written and are now available based on automatic edge
detection in the images, in order to obtain reproducible results
(Judex et al., 2010). MicroCT can also allow determining the
degree of fat infiltration in liver by measuring the liver-to-spleen
density ratio in a specific region around the intervertebral disk
between the 13th thoracic and first lumbar vertebrae (Judex et al.,
2010).
MicroCT was used to investigate the effect of high frequency
and low intensity mechanical signals on adipogenesis in mice
(Rubin et al., 2007). This study demonstrated that 15 weeks of
brief, daily exposure to high-frequency mechanical signals of a
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magnitude well below that which would arise during walking,
inhibits adipogenesis by 27% in C57BL/6J mice.
Using microCT scanning, a reduced percentage of adipose
mass associated with decreased adipocyte cell size was found
in mice null for Fyn (a member of the Src family of non-
receptor tyrosine kinases). Such reduction was accompanied
by a substantial reduction in fasting plasma glucose, insulin,
triglycerides and free fatty acids, concomitant with decreased
intrahepatocellular and intramyocellular lipid accumulation. For
the quantification of total fat volume inside a volume of interest,
freshly harvested fat pad from similar mouse, with identical scan
settings, were imaged in order to identify the upper and lower
thresholds useful to separate adipose tissues from other tissues
and fluids (Bastie et al., 2007).
A study on BAT was conducted on rats exposed to room
temperature (23–24◦C) as the control condition and after 4 h of
cold exposure (4◦C), which is known to activate BAT. The CT
Hounsfield units (which are related to the tissutal radiodensity)
of BAT resulted higher (whiter density in the images) under the
activated condition than under the control condition (Baba et al.,
2010).
PET Imaging
Positron emission tomography is a nuclear medicine imaging
technique used to reveal functional processes in living organisms.
The main applications are in oncology, neuroimaging,
cardiology, infectious disease, musculoskeletal imaging, and
pharmacokinetics studies. PET is routinely used on humans and,
in preclinical applications, on experimental animals. As far as fat
imaging is concerned, applications of PET are limited to BAT.
Positron emission tomography instruments are able to detect
pairs of gamma rays emitted in living bodies by i.v. injected
radiotracers. The radiotracers used in PET contain positron-
emitting isotopes, i.e., isotopes decaying by emitting positive
charged electrons, called positrons. The positron can travel for
about 1 mm in biological tissues before it loses most of its
energy and encounters an electron. The interaction annihilates
both particles producing two gamma rays emitted in opposite
directions. The gamma rays are detected by scintillator crystals
(of which the internal ring of the tomograph is made) generating
bursts of light revealed by photomultiplier tubes (or avalanche
photodiode) coupled with the crystals. Each light burst is then
converted in electric signal. The detection of two different, almost
simultaneous, events in crystals located approximately at 180
degrees with respect to the center of the tomograph is referred
to as a coincidence and the signal is considered due to a real
nuclear decay event. Noise or spurious events are attributable to
the interaction of cosmic rays or natural radioactivity within the
instrument.
The decay time of radioisotopes for PET applications is
preferably chosen short enough to reduce the radiation exposure
of patients, but at the same time, long enough to allow chemical
synthesis and transport from the production site to the imaging
facility. The most commonly used radiotracer in PET imaging is
2-deoxy-2-18F-fluoro-D-glucose (18F-FDG), an analog of glucose,
which is labeled with 18 Fluorine. The half-life time of 18F is
110 min. 18F-FDG is internalized by cells in proportion to their
metabolic activity so it accumulates preferentially in cancer cells,
brain, heart, and kidney. Inside cells, 18F-FDG cannot be further
metabolized and it cannot move out of the cell before radioactive
decay. Consequently, the distribution of 18F-FDG reflects well
metabolic rate in body tissues and consequently it is the most
relevant radiotracer for studies of BAT metabolism.
Fueger et al. (2006) investigated the uptake of 18F-FDG in BAT
of mice under different experimental conditions. It is well known
that BAT metabolism is activated in mice by low temperature
to generate heat. Consequently, the uptake of 18F-FDG in BAT
was found to be higher at room temperature (21◦C) than at
thermoneutrality (30◦C). 18F-FDG uptake by BAT was reduced
by fasting the animals overnight, in accordance with the well-
known role of BAT in postprandial thermogenesis.
18F-FDG uptake in BAT also increases in mice exposed to
full-thickness thermal injury (30% of total body surface area),
cold stress (4◦C for 24 h) or cutaneous wounds (5-fold, 15-
fold, and 15-fold, respectively), whereas the uptake in adjacent
WAT is unchanged (Carter et al., 2011). Using a thermal imaging
camera, a linear relationship between 18F-FDG uptake and BAT
temperature was demonstrated for the first time in in vivo studies
(Carter et al., 2011).
18F-FDG-PET imaging was used to investigate the diurnal
rhythm of glucose uptake in C57Bl/6 mice: glucose uptake in
iBAT peaks at approximately 9 h into the light phase of the
12 h light period. This result makes iBAT a candidate site of
interaction between metabolic and circadian systems (van der
Veen et al., 2012).
Pharmacological approaches were used to demonstrate that
adrenergic pathway activation enhances BAT metabolism in
rodents (Mirbolooki et al., 2011, 2013, 2014). BAT is innervated
by sympathetic noradrenergic nerve fibers whose stimulation
activates β3-adrenoreceptors in the target tissue resulting in
enhancement of glycolysis. This probably increases the synthesis
of cyclic AMP and the overexpression of uncoupling protein-
1 (UCP1). In the first study, BAT activation was induced by
administration of CL316243, a β3 adrenoceptor agonist in rats,
and evaluated by 18F-FDG-PET imaging (Mirbolooki et al.,
2011). CL316243-induced activation of BAT was clearly visible
in PET images, in particular in the interscapular, cervical,
periaortic, and intercostal BAT deposits. The uptake of 18F-
FDG was enhanced by 12-fold in comparison to control animals,
while low temperature (8◦C for 120 min) increased the 18F-
FDG uptake only 1.1-fold (Figure 3). The uptake of 18F-FDG
in activated iBAT was greatly reduced (96.0%) by administration
of the β-blocker propranolol. These results were confirmed by
ex vivo 18F-FDG autoradiography and histology. In a second
study, the effect of presynaptic activation with atomoxetine
on BAT metabolism was evaluated in rats (Mirbolooki et al.,
2013). The existence of norepinephrine transporters in BAT
was previously suggested by in vivo and ex vivo evaluations
using 11C-MRB, a highly selective norepinephrine transporter
ligand for BAT imaging at room temperature in rats (Lin et al.,
2012). It is noticeable that for this study the positron emitter
11C with 20.3 min half-life was used. The results obtained in
the studies previously mentioned were confirmed and extended
to mice using three pharmacological approaches (atomoxetine,
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FIGURE 3 | Coronal, sagittal and transverse views of PET/CT images. The images show CL316243 activated BATs in Sprague-Dawley rats: PET (Left), CT
(Middle), and fused PET/CT (Right) (from Mirbolooki et al., 2011, reprinted with permission).
CL316243, and forskolin, an adenylyl cyclase enzyme activator)
in a third study (Mirbolooki et al., 2014). Atomoxetine increased
18F-FDG uptake of iBAT 1.7-fold vs. control mice. CL316243
increased 18F-FDG uptake fivefold in IBAT, 2.4-fold in WAT and
2.7-fold in muscle vs. control mice. Finally, forskolin increased
the uptake 1.9 in IBAT, 2.2-fold in WAT and 5.4-fold in heart
compared to controls.
Beyond its role in thermal homeostasis (during both acute
stress and cold acclimation), BAT is probably involved in energy
homeostasis as a site of postprandial thermogenesis. The ablation
of the essential protein for heat production in BAT namely, the
uncoupling protein-1 (UCP-1), leads to an obese phenotype in
mice housed at thermoneutral temperature (Feldmann et al.,
2009). BAT was found to be involved in plasma triglyceride
clearance (Bartelt et al., 2011) and glucose homeostasis (Guerra
et al., 2001; Gunawardana and Piston, 2012). Accordingly to
Vosselman et al. (2013) these results highlight the antiobesity
role of BAT in rodents, as well as its potential in obesity-related
metabolic diseases (diabetes and cardiovascular disease).
Activation of BAT can be a new strategy to combat obesity
and diabetes mellitus (DM). Wu et al. (2014) obtained models
of obesity by feeding mice with a high fat diet for 8 weeks and
models of DM by administration of streptozotocin to obese mice.
Both obese and DM mice showed lower 18F-FDG uptake in iBAT
compared to controls. After 2 weeks of treatment with BRL37344
(a β3-adrenergic receptor agonist) the uptake was significantly
increased in both animal models with a decrease of blood glucose
levels and substantial weight loss in obese mice. Levothyroxine
(the synthetic thyroid hormone) increased 18F-FDG uptake in
both obese and control mice, but not in DM mice. These results
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demonstrate that inhibition of BAT function found in obese
and DM mice can be reversed by β3-adrenergic receptor agonist
or thyroid hormone administration (Wu et al., 2014) and BAT
activation may effectively lead to weight loss and blood glucose
lowering.
To evaluate the significance of β3-adrenoreceptor agonist-
induced BAT activation in obesity, a useful rat model is
represented by the Zucker lean and obese rats. The effect of
CL316243 administration on the BAT 18F-FDG uptake was
investigated in both genotypes, resulting in fourfold increase of
glucose uptake in Zucker lean with respect to saline-administered
control rats and only a twofold increase in Zucker obese rats.
The reduced CL316243 activation is consistent with the lower β3-
adrenoreceptor levels in Zucker obese with respect Zucker lean
rats (Schade et al., 2015).
A norepinephrine analog labeled with the 11C isotope ((11)C-
meta-hydroxyephedrine, 11)C-MHED) was used to investigate
the sympathetic nervous system (SNS) activity in BAT of lean and
dietary obese mice, demonstrating that 11C-MHED is a specific
marker of the SNS-mediated thermogenesis in BAT deposits,
and that this radiotracer can detect in vivo the WAT-to-BAT
conversion (Quarta et al., 2013).
Recently, concomitant application of 11C-acetate, 18FDG, and
18F-fluoro-thiaheptadecanoic acid (18FTHA) has been reported
in order to characterize BAT alterations in both clinical
(Ouellet et al., 2012) and preclinical studies (Labbé et al.,
2015, 2016). In preclinical studies, the effects of cold on BAT
were investigated using 18F-FDG (for glucose uptake), 18FTHA
(for non-esterified fatty acid–NEFA- uptake), and 11C-acetate
(for oxidative activity). The experiment was performed in rats,
adapted to 27◦C, which were acutely subjected to cold (10◦C)
for 2 or 6 h and in rats chronically adapted to 10◦C for 21 days,
which were returned to 27◦C for 2 or 6 h. Cold exposure (acute
and chronic) led to increases in BAT oxidative activity, which
was accompanied by concomitant increases in glucose and NEFA
uptake (Labbé et al., 2015). The same radiotracers were used
to investigate the metabolic activity of iBAT and “beige adipose
tissue” in mice exposed to cold or to an adrenergic agonist
(CL) (Labbé et al., 2016) extending the results found in humans
(Ouellet et al., 2012).
Finally, an experimental protocol for BAT functional imaging
with 18F-FDG in mice was proposed by Wang et al. (2012)
in order to standardize the imaging procedures, to uniform
the post-images analysis and to quantify the FDG uptake in
BAT as percentage of the injected dose per gram of tissue. The
described method, which is based on a small animal- micro-
PET/CT system, can be applied to screening drugs/compounds
that modulate BAT activity, or to identify genes/pathways that
are involved in BAT development and regulation in preclinical
studies.
Other Imaging Techniques: Cerenkov
Luminescence Imaging and
Fluorescence Imaging
It has been recently reported that beta+ or beta− emitting
radionuclides can be detected in living animals by Cerenkov
Luminescence imaging (CLI) using standard optical imaging
instrumentation (Boschi and Spinelli, 2014; Spinelli and Boschi,
2015). This methodology relies on the well-known Cerenkov
effect. Briefly, while traveling in the biological tissues, the
emitted particles polarize molecules of the medium which emit
electromagnetic waves relaxing back to the equilibrium. If the
particle travels with a speed greater than the speed of light in
the medium, the electromagnetic waves interfere constructively
producing a shock front, which can be detected in the UV-visible-
near infrared range as Cerenkov radiation.
Brown adipose tissue and its activation can be studied by
optical techniques, via CLI, as shown by Zhang et al. (2013) after
administration of 18F-FDG in mice. They demonstrated that CLI
is able to detect iBAT in vivo. Data were confirmed by ex vivo
radioactivity measurements; representative images are shown in
Figure 4A. Using norepinephrine as a stimulator, they found
that norepinephrine-treated mice show significantly higher CLI
signals compared to untreated mice. Moreover, in treated animals
they observed an increase of the signal under short (5 min)
FIGURE 4 | (A) Cerenkov luminescence images of a mouse at 30, 60, 120 min after10.3 MBq 18F-FDG intravenous injection (from Zhang et al., 2013, reprinted with
permission); (B) Fluorescence images of living SKH1 hairless mice after intravenous 10 nmol dose of SRFluor680 [A], IR780 [B], or Nile Red [C] and imaged
periodically over a period of 6 h. The fluorescence pixel intensity scale bar applies to all images in the same row (arbitrary units) (from Rice et al., 2015, reprinted with
permission).
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isoflurane anesthesia (1.23-fold) and a greater increase after long
(60 min) isoflurane anesthesia (2.47-fold). Finally, they reported
a 39% increase in 18F-FDG uptake in BAT of animals stimulated
by cold exposure.
Fluorescence imaging is based on the detection of light
coming from exogenous fluorochromes (dyes or genetically
engineered fluorescent proteins) excited with light sources (laser
or lamps). The photons escaping from the sample surface
are generally detected by a charge CCD with high quantum
efficiency. Excitation and emission wavelengths suitable for
in vivo investigations are in the red-near infrared region (650–
800 nm) where the biological tissues are optically thin. Outside
this “transparency window” the substantial absorption of oxy-
and deoxy-hemoglobin, melanin, water and fat reduces the
light signal. Fluorescence imaging is a very simple, safe, and
cost-effective technique, which has been implemented to obtain
tomographic 3D reconstructions of the light sources inside the
body (Beckmann et al., 2007).
A pure optical approach to the detection of BAT was
recently reported by Rice et al. (2015) who administered mice
with a micellar formulation of commercially available deep-
red fluorescent probe (SRFluor680). They showed an extensive
uptake of the fluorescent probe in iBAT, as clearly visible
in Figure 4B. The results were confirmed by 18F-FDG PET
imaging and ex vivo examinations. They explained the results
by an irreversible translocation of the lipophilic fluorescent
probe from the micelle nanocarrier to the adipocytes within
the BAT. The authors suggest that combining optical methods
with FDG/PET could constitute a path toward a new molecular
imaging paradigm allowing non-invasive visualization of BAT
mass and BAT metabolism in living subjects.
CONCLUSION
Magnetic Resonance Imaging, CT, and PET represent a panel
of imaging techniques which are instrumental for the in vivo
detection and quantification of fat tissues in cross sectional
and longitudinal studies. Several qualitative and quantitative
morphological and functional data can be extracted from images,
allowing for the investigation of fat tissue metabolism and drug
response. Techniques based on MRI and MRS are considered
the most comprehensive tools for quantification of fat in
living organisms. MRI based techniques allow to investigate the
anatomical distribution of adipose tissues, the presence of ectopic
fat, and also chemical and functional state of fat deposits with
high space resolution. MicroCT can discriminate fat tissue from
remaining soft tissue in small laboratory animals with similar
space resolution. PET suffers from limited space resolution
(around 1 mm), from the need for expensive radiotracers and
controlled environment, but it has been proven to be extremely
sensitive in studies of BAT activation. Indeed MRI, CT and
PET should be regarded as a set of complementary techniques.
Much effort is currently in progress toward multimodal imaging
approaches: hybrid instruments combining PET and MRI, or
PET and CT, have been developed also for small animal imaging
to overcome the limitations of individual techniques. MRI, CT,
and PET are used in both clinical and preclinical fields, thereby
enhancing the translational value of findings in experimental
animals. A limitation of these techniques is the high cost of
instrumentation and maintenance, and the need for specialized
personnel. Accordingly, large studies employing tens or hundreds
of animals are cumbersome. However, microCT, PET and,
especially, MRI are non-invasive and allow for longitudinal
studies where a reduced number of animals is sufficient in order
to obtain statistically significant results. Recently other imaging
techniques (CLI and fluorescence imaging) have been applied to
these topics, but still await full validation.
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